Showing 1 - 10 of 101
2020 was a challenging year globally. However, the start of 2021 has welcomed the rapid roll out of the breakthrough COVID-19 vaccines in the UK, a ray of hope for a way out of the pandemic. Over 20 million people in the UK have already been given vaccine doses, with the hope that the majority of the UK adult population will be vaccinated by the end of 2021.
The outcome of two Canadian product class actions in 2020 signal hurdles claimants may face around the globe in 2021 in alleging adverse health effects in mass tort claims involving products for consumption such as medical cannabis, other pharmaceutical products and food.
The fourth edition of our most popular guide for claims handlers has launched, helping empower insurers, third party administrators, corporates and their claims teams to become less reliant on their lawyers
This report examines the key features of the Directive of the European Parliament and of the European Council on representative actions for the protection of the collective interests of consumers and its wider impact on consumer-led litigation across Europe, including comparative insights into national class action mechanisms in the United Kingdom, Belgium, Denmark, France, Portugal, Spain and Ireland.
While 2020 was undoubtedly the year of the COVID-19 pandemic, 2021 is becoming the year of the vaccination. In this article, our industry experts consider the latest developments relating to the vaccine and provide an overview of its impact on various sectors.
On the surface, the London Market enters 2021 looking very different to its 2020 version. Underwriting rooms lay empty, offices unoccupied, pubs eerily quiet. But beyond the physical stillness, this world leading hub has not paused for breath. Digital systems and solutions have taken centre stage as the London Market has responded to a seismic shift in working patterns and insurance risks.
Kennedys has appointed partner Sarah-Jane Dobson to its growing international products law practice. Sarah-Jane, who joins from Cooley LLP and will be based in Kennedy’s London office, specialises in litigation and regulatory matters relating to product safety, product compliance and product liability.
Case review 15-12-2020
Further to our previous update, on 11 December 2020, the Supreme Court dismissed Mastercard’s appeal against Walter Merricks. This landmark decision takes us a step closer to the granting of what would be the largest group action in the history of England and Wales.
Kennedys is celebrating 20 years in Hong Kong, and is also moving to new offices.
Kennedys has announced that partners Victoria Clucas and Bill Evans have moved from London to Dubai as part of the firm’s plans to strengthen its capabilities across the Gulf and Middle East region.